900 Cyclists to Raise Money for MS in Biking Event in Quebec This Weekend
The Quebec Division of the Multiple Sclerosis Society of Canada (MSSC)Ā announced that this year’sĀ 27th Medavie Blue Cross MS Bike, a fundraising bike ride on roads alongside St. Lawrence River, will take place Aug. 27 and 28Ā in the Mauricie region.
A total of 900 cyclists are setĀ toĀ participate in the ride, which traverses the regionās villages, to raise moneyĀ for multiple sclerosis (MS) researchĀ and to add to theĀ nearly $17 millionĀ MS Bike has raisedĀ since its inception. Ā The Medavie Blue Cross MS Bike is organized by MSSC in collaboration with VĆ©lo QuĆ©bec ĆvĆ©nements.
“Medavie Blue Cross is thrilled to be title sponsor of the MS Bike Tour inĀ QuebecĀ again this year,” Eric Laberge, president of Medavie Blue Cross, said in a press release. “Multiple sclerosis is a leading health concern for Canadians. We are committed to supporting research and programs to help those impacted by MS through our support of the MS Society.
“The MS Bike Tour is a fun and healthy event that has a tremendous impact in our province,” he added. “Together with our employees, we care about our community’s health and believe that we can build a future without MS.”
Canada has the highest rate of MS in the world.
Spokeswoman for this year’s event is ValĆ©rie Chevalier, a columnist withĀ Salut, Bonjour!, who will cycle with her friend and team leader Christiane Thouin, an MS patient.
MS Bike is the largestĀ cycling fundraising event inĀ North America, with tours involving more thanĀ 10,000 cyclists takingĀ placeĀ from June to September across the country. Anyone interested in finding out more out these ridesĀ canĀ visitĀ msbike.ca.
MS, a chronic and disabling disease of the central nervous system (CNS), is often diagnosed in people betweenĀ the ages of 15 and 40. Ā The MSSCĀ Ā supportsĀ researchĀ intoĀ the cause, improved treatments, and a potential cure for MS, and provides services for patients and their families.
To keep updated on events like this, as well as developments inĀ ongoing research into multiple sclerosis, subscribe to Multiple Sclerosis News Today and receive our weekly newsletter directly in your email.